Johnson & Johnson’s third-quarter profit jumped 23 percent, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world’s biggest maker of health care products ...
Tagged with: 3Q J&J Johnson & Johnson Wall Street
Read More »